CA2512586A1 - Dual function uv-absorbers for ophthalmic lens materials - Google Patents
Dual function uv-absorbers for ophthalmic lens materials Download PDFInfo
- Publication number
- CA2512586A1 CA2512586A1 CA002512586A CA2512586A CA2512586A1 CA 2512586 A1 CA2512586 A1 CA 2512586A1 CA 002512586 A CA002512586 A CA 002512586A CA 2512586 A CA2512586 A CA 2512586A CA 2512586 A1 CA2512586 A1 CA 2512586A1
- Authority
- CA
- Canada
- Prior art keywords
- ch2ch3
- absorber
- benzotriazole
- benzophenone
- nothing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/04—Azo-compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/3467—Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
- C08K5/3472—Five-membered rings
- C08K5/3475—Five-membered rings condensed with carbocyclic rings
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Materials Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Materials For Medical Uses (AREA)
- Polymerisation Methods In General (AREA)
- Prostheses (AREA)
- Eyeglasses (AREA)
- Silicon Polymers (AREA)
- Optical Filters (AREA)
- Polymerization Catalysts (AREA)
Abstract
Disclosed are UV absorbers that contain a labile functional group capable of initiating free radical polymerization.
Description
DUAL FUNCTION UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS
s Field of the Invention This invention is directed to ophthalmic lens materials. In particular, this invention relates to ultraviolet light absorbers that also act as polymerization initiators for ophthalmic lens materials.
Background of the Invention Many UV light absorbers are known as ingredients for polymeric materials used to make ophthalmic lenses. UV absorbers are preferably covalently bound to the polymeric network of the lens material instead of ~s simply physically entrapped in the material to prevent the absorber from migrating, phase separating or leaching out of the lens material. Such stability is particularly important for implantable ophthalmic lenses where the leaching of the UV absorber may present both toxicological issues and lead to the loss of UV blocking activity in the implant.
Numerous copolymerizable benzatriazole, benzophenone and triazine UV absorbers are known. Many of these UV absorbers contain conventional olefinic polymerizable groups, such as methacrylate, acrylate, methacrylamide, acrylamide or styrene groups. Copolymerization with other 2s ingredients in the lens materials, typically with a radical initiator, incorporates the UV absorbers into the resulting polymer chain. Incorporation of additional functional groups, on a UV absorber may influence one or more of the UV
absorber's UV absorbing properties, solubility or reactivity. If the UV
absorber does not have sufficient solubility in the remainder of the ophthalmic lens so material ingredients or polymeric lens material, the UV absorber may coalesce into domains that could interact with light and result in decreased optical clarity of the lens.
Examples of polymeric ophthalmic lens materials that incorporate UV
absorbers can be found in U.S. Patent Nos. 5,290,892; 5,331,073 and 5,693,095.
s Summary of the Invention The present invention provides dual function UV absorbers. These UV
absorbers contain a labile functional group capable of initiating radical polymerization. These UV absorbers are suitable for use in ophthalmic~Y
lenses, including contact lenses, and are particularly useful in implantable lenses, such as intraocular lenses (IOLs).
Among other factors, the present invention is based on the finding that UV absorbers can be modified to incorporate a labile functional group ~s capable of initiating polymerization of an olefinic ophthalmic lens material monomers without eliminating the UV absorber's UV absorbing activity, solubility or reactivity with ophthalmic lens material ingredients.
Detailed Description of the Invention ao Unless indicated otherwise, all ingredient amounts expressed in percentage terms are presented as % w/w.
The dual function UV absorbers ("DFUVAS") of the present invention zs contain a functional group that can initiate free radical polymerization.
As such, these DFUVAS eliminate the need for two separate monomeric ingredients in the preparation of copolymeric ophthalmic lens materials.
Instead of adding a conventional UV absorber to conventional ophthalmic lens-forming materials and separately adding a conventional polymerization 3o initiator, a DFUVAS can be used in place these two conventional ingredients.
s Field of the Invention This invention is directed to ophthalmic lens materials. In particular, this invention relates to ultraviolet light absorbers that also act as polymerization initiators for ophthalmic lens materials.
Background of the Invention Many UV light absorbers are known as ingredients for polymeric materials used to make ophthalmic lenses. UV absorbers are preferably covalently bound to the polymeric network of the lens material instead of ~s simply physically entrapped in the material to prevent the absorber from migrating, phase separating or leaching out of the lens material. Such stability is particularly important for implantable ophthalmic lenses where the leaching of the UV absorber may present both toxicological issues and lead to the loss of UV blocking activity in the implant.
Numerous copolymerizable benzatriazole, benzophenone and triazine UV absorbers are known. Many of these UV absorbers contain conventional olefinic polymerizable groups, such as methacrylate, acrylate, methacrylamide, acrylamide or styrene groups. Copolymerization with other 2s ingredients in the lens materials, typically with a radical initiator, incorporates the UV absorbers into the resulting polymer chain. Incorporation of additional functional groups, on a UV absorber may influence one or more of the UV
absorber's UV absorbing properties, solubility or reactivity. If the UV
absorber does not have sufficient solubility in the remainder of the ophthalmic lens so material ingredients or polymeric lens material, the UV absorber may coalesce into domains that could interact with light and result in decreased optical clarity of the lens.
Examples of polymeric ophthalmic lens materials that incorporate UV
absorbers can be found in U.S. Patent Nos. 5,290,892; 5,331,073 and 5,693,095.
s Summary of the Invention The present invention provides dual function UV absorbers. These UV
absorbers contain a labile functional group capable of initiating radical polymerization. These UV absorbers are suitable for use in ophthalmic~Y
lenses, including contact lenses, and are particularly useful in implantable lenses, such as intraocular lenses (IOLs).
Among other factors, the present invention is based on the finding that UV absorbers can be modified to incorporate a labile functional group ~s capable of initiating polymerization of an olefinic ophthalmic lens material monomers without eliminating the UV absorber's UV absorbing activity, solubility or reactivity with ophthalmic lens material ingredients.
Detailed Description of the Invention ao Unless indicated otherwise, all ingredient amounts expressed in percentage terms are presented as % w/w.
The dual function UV absorbers ("DFUVAS") of the present invention zs contain a functional group that can initiate free radical polymerization.
As such, these DFUVAS eliminate the need for two separate monomeric ingredients in the preparation of copolymeric ophthalmic lens materials.
Instead of adding a conventional UV absorber to conventional ophthalmic lens-forming materials and separately adding a conventional polymerization 3o initiator, a DFUVAS can be used in place these two conventional ingredients.
Many conventional thermal free radical initiators and many UV
absorbers are known. The DFUVAS may be synthesized by reacting a UV
absorber that contains a reactive functionality with a radical initiator while preserving the radical generating linkage. For example, 3-(2H-benzotriazol-2-s yl)-4-hydroxyphenethyl alcohol (1 ) may be coupled to 4,4'-azobis(4-cyanopentanoic acid) (2) using a carbodiimide esterification agent. The product (3) can then initiate radical polymerization of a vinyl monomer (e.g., acrylate, methacrylate, acrylamide, methacrylamide, styrene) by application of heat and/or UV/visible light and the UV absorbing functionality will be covalently attached to the polymer chain.
HO O CH3 H3 HO / I O CH3 H3 N%\ //
NN - + HO~NcN~OH ' N,N~O~N:N~O ~ N~ YN
N ~ ~ CN CN O / /~N CN CN O I ~ OH
CHpCH~OH
~s This invention provides the synthesis of a single component additive that provides a dual function: UV absorption properties and ability to initiate free radical polymerization. The result is a covalently linked UV absorber that will not leach out of the product or phase separate and lead to decreased optical clarity. The synthesis permits flexibility in tailoring both UV
absorbing zo strength and initiator half-life. UV-initiation of polymerization of the lens material is still possible with protection of the hydroxy group on the UV
absorbing function of the DFUVAS.
The DFUVAS can be synthesized from azo, organic peroxide, is phosphine oxide, and a-hydroxyketone radical polymerization initiators that contain appropriate functional groups. The necessary functionality from each of these initiator classes is the presence of a functional group (carboxylic acid or hydroxyl) through which a UV absorbing benzotriazole, benzophenone or triazine can be covalently linked. Preferred DFUVAS are those represented by formulas [1] - [7].
Several functionalized azo initiators are commercially available. For s example, V-501 (4,4'-azobis(4-cyanopentanoic acid)) from Wako Chemicals.
This initiator contains a thermally labile azo linkage (-N=N-) and two terminal carboxylic acid groups. Similarly, VA-086 contains two terminal hydroxyl groups. VA-080 contains three hydroxyl groups on each side of the thermally labile azo linkage.
to HO O CH3 CH3 lil O CH3 CH3 O CH3 CH3 H OH HO N,~ ~N
HO~N~~N~OH HO~N~N.~N~N OH ~N~ N~ OOH
CN CN O HO H CN N IC fOI ~ H CN NC O
OH
Therefore, an azo functional UV absorber can be synthesized from an azo initiator with the following structural characteristics:
~s O A A O
G-F-E-C-D-~--N=N-~-D-C-E-F-G
B B
where:
A is -CH3 or -CH2CH3.
zo B is -CN, -C02H, -COH, -COCH3, -C02CH3, -S03H, -CF3, or -NOZ when D is (CH2)", and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)X or (CH2CH20)XCH2CH2 where x = 1-10.
Zs G is -R, -OR, -NHR, -NRR', -C02R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
absorbers are known. The DFUVAS may be synthesized by reacting a UV
absorber that contains a reactive functionality with a radical initiator while preserving the radical generating linkage. For example, 3-(2H-benzotriazol-2-s yl)-4-hydroxyphenethyl alcohol (1 ) may be coupled to 4,4'-azobis(4-cyanopentanoic acid) (2) using a carbodiimide esterification agent. The product (3) can then initiate radical polymerization of a vinyl monomer (e.g., acrylate, methacrylate, acrylamide, methacrylamide, styrene) by application of heat and/or UV/visible light and the UV absorbing functionality will be covalently attached to the polymer chain.
HO O CH3 H3 HO / I O CH3 H3 N%\ //
NN - + HO~NcN~OH ' N,N~O~N:N~O ~ N~ YN
N ~ ~ CN CN O / /~N CN CN O I ~ OH
CHpCH~OH
~s This invention provides the synthesis of a single component additive that provides a dual function: UV absorption properties and ability to initiate free radical polymerization. The result is a covalently linked UV absorber that will not leach out of the product or phase separate and lead to decreased optical clarity. The synthesis permits flexibility in tailoring both UV
absorbing zo strength and initiator half-life. UV-initiation of polymerization of the lens material is still possible with protection of the hydroxy group on the UV
absorbing function of the DFUVAS.
The DFUVAS can be synthesized from azo, organic peroxide, is phosphine oxide, and a-hydroxyketone radical polymerization initiators that contain appropriate functional groups. The necessary functionality from each of these initiator classes is the presence of a functional group (carboxylic acid or hydroxyl) through which a UV absorbing benzotriazole, benzophenone or triazine can be covalently linked. Preferred DFUVAS are those represented by formulas [1] - [7].
Several functionalized azo initiators are commercially available. For s example, V-501 (4,4'-azobis(4-cyanopentanoic acid)) from Wako Chemicals.
This initiator contains a thermally labile azo linkage (-N=N-) and two terminal carboxylic acid groups. Similarly, VA-086 contains two terminal hydroxyl groups. VA-080 contains three hydroxyl groups on each side of the thermally labile azo linkage.
to HO O CH3 CH3 lil O CH3 CH3 O CH3 CH3 H OH HO N,~ ~N
HO~N~~N~OH HO~N~N.~N~N OH ~N~ N~ OOH
CN CN O HO H CN N IC fOI ~ H CN NC O
OH
Therefore, an azo functional UV absorber can be synthesized from an azo initiator with the following structural characteristics:
~s O A A O
G-F-E-C-D-~--N=N-~-D-C-E-F-G
B B
where:
A is -CH3 or -CH2CH3.
zo B is -CN, -C02H, -COH, -COCH3, -C02CH3, -S03H, -CF3, or -NOZ when D is (CH2)", and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)X or (CH2CH20)XCH2CH2 where x = 1-10.
Zs G is -R, -OR, -NHR, -NRR', -C02R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
Many benzotriazole and benzophenone UV absorbers are known and many are commercially available from a variety of sources, such as Ciba Specialty Chemicals. The identity of the benzotriazole or benzophenone UV
absorber is not critical, but should be selected based on its characteristic UV
s cut-off to give the desired UV absorbing property. For IOL applications, preferred benzotriazole UV absorbers are hydroxyphenylbenzotriazoles and preferred benzophenone UV absorbers are hydroxyphenylbenzophenones that have been modified to contain a functional group that can be covalently bonded to a radical polymerization initiator. For example, a preferred hydroxyphenylbenzotriazole UV absorber is 2-N-(2-hydroxyphenyl)benzotriazole, where the UV absorbing group is linked through an ethyl ether linkage at the para position on the hydroxyphenyl group, as shown below linked to an azo functionality.
HO / I O CH3 CH3 N=1 //
N,N \ O~N;N~O \ N, ~N
~N ~ 'CN ~CN~ ~O I ~ OH
is (3) Functionalized a-hydroxyketones suitable for use as UV polymerization initiators are commercially available. For example, 2-hydroxy-1-[4-(2-hydroxy-zo ethoxy)phenyl]-2-methylpropan-1-one (Irgacure~ 2959, Ciba Specialty Chemicals) contains a free primary hydroxyl group covalently attached to a UV light labile a-hydroxyketone linkage. This primary hydroxyl can be used as a covalent linking point. For example, in Irgacure~ 2959, the primary hydroxyl was used to covalently attach hydrophilic functional groups through an ether Zs linkage to create a water-soluble photoinitiator (Gruber, H. F.; Knaus, S.
J.
Polym. Sci. Part A: Polym. Chem. 1995, 33, 929).
off No Irgacure~ 2959 A generic a-hydroxyketone photoinitiator that contains the appropriate functional groups for covalently linking a UV chromophore is represented by formula [2]:
s of L~C-C-OH
[2~ G. J
where:
J is CH3 or CHZCH3.
L is nothing, (CH2)Y or (CH2CH20)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
Functionalized phosphine oxide photoinitiators are also known. For ~s example, a vinyl functional phosphine oxide was used in the synthesis of polymeric acylphosphine oxide photoinitiators (DeGroot, J. H.; Dillingham, K.
A.; Deuring, H.; Haitjema, H. J.; Van Beijma, F. J.; Hodd, K. A.; Norrby, S.
Biomacromolecules 2001, 2, 1271 ).
/ \ P_°
\/
A generic phosphine oxide photoinitiator that contains the appropriate functional groups for covalently linking a UV chromophore is represented by formula [3].
2s G, G
T~ ~ O O -~P-C ~ ~ Q
T
Q ~G
~,J
,T
[3~ G
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)~, or -(OCH2CH2)Z, where z = 1 -10 s G is -R, -OR, -NHR, -NRR', -C02R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
Functionalized organic peroxides are less common, however the presence of a functional group for example OH, NH2, or CO2H would allow covalent attachment of a benzotriazole- or benzophenone-containing UV
chromophore. A generic acylperoxide initiator that contains appropriate functional groups for covalently linking a UV chromophore is represented by formula [4].
O O
is [4] R~Y~O-O~Y~R
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)nH (n = 1-1~); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -20 C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4Fi; -C(CHs)2(CH2)5H, -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CHZ)6H; -/~ CH3 --( r--C-CH3 CH2CH(CH2CH3)(CH2)4H; or ~/ ~"3 By way of illustration, if Y=O and R and R' in formula [4] are selected as to be the benzotriazole UV absorber 2-N-(2-hydroxyphenyl)benzotriazole, and the UV absorbing group is linked through an ethyl linkage at the para position on the hydroxyphenyl group to the peroxydicarbonate functionality, the following compound is obtained:
NO O O OH
N,N ~ I O~O-O~O ~ I N,N
~N N
s Generic peroxyester, dialkylperoxide and peroxyketal initiators that contain the appropriate functional groups for covalently linking a UV chromophore are represented by formulas [5], [6], and [7], respectively.
o io [5] ~o-o-R~ (peroxyester) where R - a benzotriazole or benzophenone UV absorber; R' - a benzotriazole or benzophenone UV absorber; -(CH2)~H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -is C(CH3)2(CI-12)4f-I; -C(CH2CH3)2(CH2)4H, -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H, /~ CH3 ~C-CHI
CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or ~H3 20 [6] R-O-O-R (dialkylperoxide) where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)"H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -2s C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H, -C(CH2CH3)2(CHZ)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5.
R
n ,0 -O
(~~(~O-O
[7] R' (peroxyketal) where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)"H (n = 1 s 18); CH(CH3)CH3; C(CH3)s; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)aH; C(CHa)2(CHZ)sH; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH~)6H; C(CH2CH3)2(CHZ)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
In general, the amount of DFUVAS contained in ophthalmic lens materials will depend upon the desired UV blocking characteristics but will typically range from 1 - 5 wt%.
The invention will be further illustrated by the following examples, which ~s are intended to be illustrative, but not limiting.
Example 1: Esterification of 4,4'-azobis(4-cyanopentanoic acid) with 3-(2H-benzotriazol-2-yl)-4-hydroxyphenethyl alcohol A 50 mL 3-neck flask was dried in a 120 °C oven overnight and cooled in a ao desiccator. The flask flushed with N2 then charged with 1.9151 g (7.50 mmol) of 3-(2H-benzotriazol-2-yl)-4-hydroxyphenethyl alcohol. The solid was dissolved in 15 mL anhydrous tetrahydrofuran, then 4-dimethylaminopyridine (0.0489g, 0.400 mmol) and 4,4'-azobis(4-cyanopentanoic acid) (1.0084 g, 3.60 mmol), were added and allowed to dissolve. 1,3-Dicyclohexyl carbodiimide zs (1.5520 g, 7.52 mmol) was added and the reaction mixture was allowed to stir at ambient temperature under a N2 blanket for 24 hr. The reaction mixture was filtered through a fine porosity sintered glass funnel and the solvent was rotovapped. The crude product was purified by column chromatography (silica gel, CH2CI2), the solvent was rotovapped and the product was dried under so vacuum. Yield 1.3691 g (1.81 mmol, 51 %) of a pale yellow powder.
Example 2: Preparation of Ophthalmic Lens Material initiated with UV
absorbing inititator prepared in Example 1.
A scintillation vial was charged with 3.3572 g (19.052 mmol) of 2-phenylethyl s acrylate (PEA), 1.5585 g (8.192 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0611 g (0.308 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.2290 g (0.304 mmol) of the UV
absorbing initiator prepared in Example 1 was added and allowed to dissolve.
The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss following extraction was determined gravimetrically and the UV/Vis spectrum ~s was recorded from 190 to 820 nm on a 1 mm thick flat. The data is listed in Table 1.
Example 3: Preparation of Ophthalmic Lens Material initiated with UV
absorbing initiator prepared in Example 1.
ao A scintillation vial was charged with 3.3502 g (19.012 mmol) of 2-phenylethyl acrylate (PEA), 1.5516 g (8.156 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0567 g (0.286 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.0761 g (0.101 mmol) of the UV
absorbing initiator prepared in Example 1 was added and allowed to dissolve.
as The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss 3o following extraction was determined gravimetrically and the UV/Vis spectrum was recorded from 190 to 820 nm on a 1 mm thick flat. The data is listed in Table 1.
Example 4: Preparation of Ophthalmic Lens Material initiated with 2,2'-azobisisobutyronitrile (AIBN) A scintillation vial was charged with 3.3580 g (19.057 mmol) of 2-phenylethyl s acrylate (PEA), 1.5629 g (8.215 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0589 g (0.297 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.0502 g (0.306 mmol) of 2,2'-azobisisobutyronitrile (AIBN) was added and allowed to dissolve. The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C
then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss following extraction was determined gravimetrically and the UV/Vis spectrum was recorded from ~s 190 to 820 nm on 1 mm thick flat. The data is listed in Table 1.
Table 1 Weight % acetone extractables and UV cut-off of ophthalmic lens materials.
Example % extractables 10% T (nm) 1 % T (nm) 2 3.86 ~ 0.18 381 377 3 4.82 ~ 0.25 377 371 4 0.63 ~ 0.23 294 279 This invention has been described by reference to certain preferred embodiments; however, it should be understood that it may be embodied in other specific forms or variations thereof without departing from its special or 2s essential characteristics. The embodiments described above are therefore considered to be illustrative in all respects and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description.
absorber is not critical, but should be selected based on its characteristic UV
s cut-off to give the desired UV absorbing property. For IOL applications, preferred benzotriazole UV absorbers are hydroxyphenylbenzotriazoles and preferred benzophenone UV absorbers are hydroxyphenylbenzophenones that have been modified to contain a functional group that can be covalently bonded to a radical polymerization initiator. For example, a preferred hydroxyphenylbenzotriazole UV absorber is 2-N-(2-hydroxyphenyl)benzotriazole, where the UV absorbing group is linked through an ethyl ether linkage at the para position on the hydroxyphenyl group, as shown below linked to an azo functionality.
HO / I O CH3 CH3 N=1 //
N,N \ O~N;N~O \ N, ~N
~N ~ 'CN ~CN~ ~O I ~ OH
is (3) Functionalized a-hydroxyketones suitable for use as UV polymerization initiators are commercially available. For example, 2-hydroxy-1-[4-(2-hydroxy-zo ethoxy)phenyl]-2-methylpropan-1-one (Irgacure~ 2959, Ciba Specialty Chemicals) contains a free primary hydroxyl group covalently attached to a UV light labile a-hydroxyketone linkage. This primary hydroxyl can be used as a covalent linking point. For example, in Irgacure~ 2959, the primary hydroxyl was used to covalently attach hydrophilic functional groups through an ether Zs linkage to create a water-soluble photoinitiator (Gruber, H. F.; Knaus, S.
J.
Polym. Sci. Part A: Polym. Chem. 1995, 33, 929).
off No Irgacure~ 2959 A generic a-hydroxyketone photoinitiator that contains the appropriate functional groups for covalently linking a UV chromophore is represented by formula [2]:
s of L~C-C-OH
[2~ G. J
where:
J is CH3 or CHZCH3.
L is nothing, (CH2)Y or (CH2CH20)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
Functionalized phosphine oxide photoinitiators are also known. For ~s example, a vinyl functional phosphine oxide was used in the synthesis of polymeric acylphosphine oxide photoinitiators (DeGroot, J. H.; Dillingham, K.
A.; Deuring, H.; Haitjema, H. J.; Van Beijma, F. J.; Hodd, K. A.; Norrby, S.
Biomacromolecules 2001, 2, 1271 ).
/ \ P_°
\/
A generic phosphine oxide photoinitiator that contains the appropriate functional groups for covalently linking a UV chromophore is represented by formula [3].
2s G, G
T~ ~ O O -~P-C ~ ~ Q
T
Q ~G
~,J
,T
[3~ G
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)~, or -(OCH2CH2)Z, where z = 1 -10 s G is -R, -OR, -NHR, -NRR', -C02R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' _ -CH3 or -CH2CH3.
Functionalized organic peroxides are less common, however the presence of a functional group for example OH, NH2, or CO2H would allow covalent attachment of a benzotriazole- or benzophenone-containing UV
chromophore. A generic acylperoxide initiator that contains appropriate functional groups for covalently linking a UV chromophore is represented by formula [4].
O O
is [4] R~Y~O-O~Y~R
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)nH (n = 1-1~); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -20 C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4Fi; -C(CHs)2(CH2)5H, -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CHZ)6H; -/~ CH3 --( r--C-CH3 CH2CH(CH2CH3)(CH2)4H; or ~/ ~"3 By way of illustration, if Y=O and R and R' in formula [4] are selected as to be the benzotriazole UV absorber 2-N-(2-hydroxyphenyl)benzotriazole, and the UV absorbing group is linked through an ethyl linkage at the para position on the hydroxyphenyl group to the peroxydicarbonate functionality, the following compound is obtained:
NO O O OH
N,N ~ I O~O-O~O ~ I N,N
~N N
s Generic peroxyester, dialkylperoxide and peroxyketal initiators that contain the appropriate functional groups for covalently linking a UV chromophore are represented by formulas [5], [6], and [7], respectively.
o io [5] ~o-o-R~ (peroxyester) where R - a benzotriazole or benzophenone UV absorber; R' - a benzotriazole or benzophenone UV absorber; -(CH2)~H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -is C(CH3)2(CI-12)4f-I; -C(CH2CH3)2(CH2)4H, -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H, /~ CH3 ~C-CHI
CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or ~H3 20 [6] R-O-O-R (dialkylperoxide) where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)"H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -2s C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H, -C(CH2CH3)2(CHZ)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5.
R
n ,0 -O
(~~(~O-O
[7] R' (peroxyketal) where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)"H (n = 1 s 18); CH(CH3)CH3; C(CH3)s; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)aH; C(CHa)2(CHZ)sH; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH~)6H; C(CH2CH3)2(CHZ)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
In general, the amount of DFUVAS contained in ophthalmic lens materials will depend upon the desired UV blocking characteristics but will typically range from 1 - 5 wt%.
The invention will be further illustrated by the following examples, which ~s are intended to be illustrative, but not limiting.
Example 1: Esterification of 4,4'-azobis(4-cyanopentanoic acid) with 3-(2H-benzotriazol-2-yl)-4-hydroxyphenethyl alcohol A 50 mL 3-neck flask was dried in a 120 °C oven overnight and cooled in a ao desiccator. The flask flushed with N2 then charged with 1.9151 g (7.50 mmol) of 3-(2H-benzotriazol-2-yl)-4-hydroxyphenethyl alcohol. The solid was dissolved in 15 mL anhydrous tetrahydrofuran, then 4-dimethylaminopyridine (0.0489g, 0.400 mmol) and 4,4'-azobis(4-cyanopentanoic acid) (1.0084 g, 3.60 mmol), were added and allowed to dissolve. 1,3-Dicyclohexyl carbodiimide zs (1.5520 g, 7.52 mmol) was added and the reaction mixture was allowed to stir at ambient temperature under a N2 blanket for 24 hr. The reaction mixture was filtered through a fine porosity sintered glass funnel and the solvent was rotovapped. The crude product was purified by column chromatography (silica gel, CH2CI2), the solvent was rotovapped and the product was dried under so vacuum. Yield 1.3691 g (1.81 mmol, 51 %) of a pale yellow powder.
Example 2: Preparation of Ophthalmic Lens Material initiated with UV
absorbing inititator prepared in Example 1.
A scintillation vial was charged with 3.3572 g (19.052 mmol) of 2-phenylethyl s acrylate (PEA), 1.5585 g (8.192 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0611 g (0.308 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.2290 g (0.304 mmol) of the UV
absorbing initiator prepared in Example 1 was added and allowed to dissolve.
The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss following extraction was determined gravimetrically and the UV/Vis spectrum ~s was recorded from 190 to 820 nm on a 1 mm thick flat. The data is listed in Table 1.
Example 3: Preparation of Ophthalmic Lens Material initiated with UV
absorbing initiator prepared in Example 1.
ao A scintillation vial was charged with 3.3502 g (19.012 mmol) of 2-phenylethyl acrylate (PEA), 1.5516 g (8.156 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0567 g (0.286 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.0761 g (0.101 mmol) of the UV
absorbing initiator prepared in Example 1 was added and allowed to dissolve.
as The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss 3o following extraction was determined gravimetrically and the UV/Vis spectrum was recorded from 190 to 820 nm on a 1 mm thick flat. The data is listed in Table 1.
Example 4: Preparation of Ophthalmic Lens Material initiated with 2,2'-azobisisobutyronitrile (AIBN) A scintillation vial was charged with 3.3580 g (19.057 mmol) of 2-phenylethyl s acrylate (PEA), 1.5629 g (8.215 mmol) of 2-phenylethyl methacrylate (PEMA), and 0.0589 g (0.297 mmol) of 1,4-butanediol diacrylate (BDDA). The monomer mixture was purged with N2 and 0.0502 g (0.306 mmol) of 2,2'-azobisisobutyronitrile (AIBN) was added and allowed to dissolve. The initiated formulation was filtered through a 0.2 micron PTFE filter and dispensed into polypropylene molds. The molds were placed in an oven for 1 hr at 70 °C
then 2 hrs at 110 °C. The product polymer was extracted in acetone at room temperature for 16 hrs. The polymer was allowed to air dry for 1.5 hr, then placed in a 60 °C vacuum oven for 3 hrs. The weight loss following extraction was determined gravimetrically and the UV/Vis spectrum was recorded from ~s 190 to 820 nm on 1 mm thick flat. The data is listed in Table 1.
Table 1 Weight % acetone extractables and UV cut-off of ophthalmic lens materials.
Example % extractables 10% T (nm) 1 % T (nm) 2 3.86 ~ 0.18 381 377 3 4.82 ~ 0.25 377 371 4 0.63 ~ 0.23 294 279 This invention has been described by reference to certain preferred embodiments; however, it should be understood that it may be embodied in other specific forms or variations thereof without departing from its special or 2s essential characteristics. The embodiments described above are therefore considered to be illustrative in all respects and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description.
Claims (10)
1. A dual function UV absorber selected from the group consisting of where:
A is -CH3 or -CH2CH3.
B is -CN, -CO2H, -COH, -COCH3, -CO2CH3, -SO3H, -CF3, or -NO2 when D is (CH2)n, and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)x or (CH2CH2O)xCH2CH2 where x = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3;
where:
J is CH3 or CH2CH3.
L is nothing, (CH2)y or (CH2CH2O)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' =-CH3 or -CH2CH3;
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)z, or -(OCH2CH2)z, where z = 1 -10 G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'=-CH3 or -CH2CH3;
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; - CH2CH(CH2CH3)(CH2)4H; or where R - a benzotriazole or benzophenone UV absorber; R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; - CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or [6] R-O-O-R
where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)n H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5; and where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)n H (n = 1-18); CH(CH3)CH3; C(CH3)3; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)4H; C(CH3)2(CH2)5H; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH2)6H; C(CH2CH3)2(CH2)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
A is -CH3 or -CH2CH3.
B is -CN, -CO2H, -COH, -COCH3, -CO2CH3, -SO3H, -CF3, or -NO2 when D is (CH2)n, and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)x or (CH2CH2O)xCH2CH2 where x = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3;
where:
J is CH3 or CH2CH3.
L is nothing, (CH2)y or (CH2CH2O)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R' =-CH3 or -CH2CH3;
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)z, or -(OCH2CH2)z, where z = 1 -10 G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'=-CH3 or -CH2CH3;
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; - CH2CH(CH2CH3)(CH2)4H; or where R - a benzotriazole or benzophenone UV absorber; R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; - CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or [6] R-O-O-R
where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)n H (n - 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5; and where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)n H (n = 1-18); CH(CH3)CH3; C(CH3)3; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)4H; C(CH3)2(CH2)5H; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH2)6H; C(CH2CH3)2(CH2)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
2. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where:
A is -CH3 or -CH2CH3.
B is -CN, -CO2H, -COH, -COCH3, -CO2CH3, -SO3H, -CF3, or -NO2 when D is (CH2)n, and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)x or (CH2CH2O)x CH2CH2 where x = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'=-CH3 or -CH2CH3.
where:
A is -CH3 or -CH2CH3.
B is -CN, -CO2H, -COH, -COCH3, -CO2CH3, -SO3H, -CF3, or -NO2 when D is (CH2)n, and -CH3 or -CH2CH3 when D is nothing.
D is nothing or (CH2)n, n= 1-10 E is O or NH, NCH3, or NCH2CH3 F is nothing, (CH2)x or (CH2CH2O)x CH2CH2 where x = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'=-CH3 or -CH2CH3.
3. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where:
J is CH3 or CH2CH3.
L is nothing, (CH2)y or (CH2CH2O)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3.
where:
J is CH3 or CH2CH3.
L is nothing, (CH2)y or (CH2CH2O)y where y = 1-10.
G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3.
4. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)z, or -(OCH2CH2)z, where z = 1 -10 G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3.
where Q is -H, -CH3, -CH2CH3, -CH(CH3)CH3, or -C(CH3)3.
T is nothing, -(CH2)z, or -(OCH2CH2)z, where z = 1 -10 G is -R, -OR, -NHR, -NRR', -CO2R, or -COR, where R = a benzotriazole or benzophenone UV absorber, and R'= -CH3 or -CH2CH3.
5. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or
where Y = nothing or O; R = a benzotriazole or benzophenone UV absorber;
R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H; -C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or
6. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where R = a benzotriazole or benzophenone UV absorber; R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or
where R = a benzotriazole or benzophenone UV absorber; R' = a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -C6H5; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; -C(CH3)2C6H5; or
7. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
[6] R-O-O-R
where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5.
[6] R-O-O-R
where R = a benzotriazole or benzophenone UV absorber; R' = H, a benzotriazole or benzophenone UV absorber; -(CH2)n H (n = 1-18); -CH(CH3)CH3; -C(CH3)3; -CH(CH3)CH2CH3; -C(CH3)2CH2C(CH3)3; -C(CH3)2(CH2)4H; -C(CH2CH3)2(CH2)4H; -C(CH3)2(CH2)5H;
C(CH2CH3)2(CH2)5H; -C(CH3)2(CH2)6H; -C(CH2CH3)2(CH2)6H; -CH2CH(CH2CH3)(CH2)4H; or -C(CH3)2C6H5.
8. The dual function UV absorber of Claim 1 wherein the UV absorber has the formula:
where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)n H (n = 1-18); CH(CH3)CH3; C(CH3)3; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)4H; C(CH3)2(CH2)5H; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH2)6H; C(CH2CH3)2(CH2)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
where R = a benzotriazole or benzophenone UV absorber;
R' = H; a benzotriazole or benzophenone UV absorber; (CH2)n H (n = 1-18); CH(CH3)CH3; C(CH3)3; CH(CH3)CH2CH3; C(CH3)2CH2C(CH3)3;
C(CH3)2(CH2)4H; C(CH2CH3)2(CH2)4H; C(CH3)2(CH2)5H; C(CH2CH3)2(CH2)5H;
C(CH3)2(CH2)6H; C(CH2CH3)2(CH2)6H; CH2CH(CH2CH3)(CH2)4H; or C(CH3)2C6H5.
9. An ophthalmic lens material comprising a dual function UV absorber of Claim 1.
10. The ophthalmic lens material of Claim 9 wherein the dual function UV
absorber is present in the ophthalmic lens material in an amount of 1 - 5 %
(w/w).
absorber is present in the ophthalmic lens material in an amount of 1 - 5 %
(w/w).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43897803P | 2003-01-09 | 2003-01-09 | |
US60/438,978 | 2003-01-09 | ||
PCT/US2003/039846 WO2004062371A1 (en) | 2003-01-09 | 2003-12-15 | Dual function uv-absorbers for ophthalmic lens materials |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2512586A1 true CA2512586A1 (en) | 2004-07-29 |
Family
ID=32713409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002512586A Abandoned CA2512586A1 (en) | 2003-01-09 | 2003-12-15 | Dual function uv-absorbers for ophthalmic lens materials |
Country Status (12)
Country | Link |
---|---|
US (4) | US7119210B2 (en) |
EP (1) | EP1581272B1 (en) |
JP (1) | JP2006513291A (en) |
AT (1) | ATE329629T1 (en) |
AU (1) | AU2003297108B2 (en) |
CA (1) | CA2512586A1 (en) |
CY (1) | CY1106142T1 (en) |
DE (1) | DE60306203T2 (en) |
DK (1) | DK1581272T3 (en) |
ES (1) | ES2262033T3 (en) |
PT (1) | PT1581272E (en) |
WO (1) | WO2004062371A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7411053B2 (en) * | 2006-05-25 | 2008-08-12 | Harruna Issifu I | Ligand-functionalized/azo compounds and methods of use thereof |
EP2081612B1 (en) * | 2006-10-13 | 2012-11-21 | Novartis AG | Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics |
EP2139871B1 (en) * | 2007-04-30 | 2010-09-01 | Alcon, Inc. | Uv-absorbers for ophthalmic lens materials |
EP2247976B1 (en) * | 2008-02-12 | 2012-08-08 | Aaren Scientific Inc. | Ophthalmic lens having a yellow dye light blocking component |
TWI453199B (en) | 2008-11-04 | 2014-09-21 | Alcon Inc | Uv/visible light absorbers for ophthalmic lens materials |
WO2010071691A1 (en) * | 2008-12-18 | 2010-06-24 | Novartis Ag | Method for making silicone hydrogel contact lenses |
RU2544540C2 (en) * | 2008-12-30 | 2015-03-20 | Новартис Аг | Trifunctional compounds absorbing uv-radiation and application thereof |
MX2012003140A (en) * | 2009-09-15 | 2012-04-20 | Novartis Ag | Prepolymers suitable for making ultra-violet absorbing contact lenses. |
TWI583673B (en) | 2010-04-02 | 2017-05-21 | 艾爾康股份有限公司 | Adjustable chromophore compounds and materials incorporating such compounds |
HUE030629T2 (en) | 2010-12-13 | 2017-05-29 | Novartis Ag | Ophthalmic lenses modified with functional groups and methods of making thereof |
TW201311621A (en) | 2011-08-15 | 2013-03-16 | Novartis Ag | UV-absorbers for ophthalmic lens materials |
US8691925B2 (en) | 2011-09-23 | 2014-04-08 | Az Electronic Materials (Luxembourg) S.A.R.L. | Compositions of neutral layer for directed self assembly block copolymers and processes thereof |
US8686109B2 (en) | 2012-03-09 | 2014-04-01 | Az Electronic Materials (Luxembourg) S.A.R.L. | Methods and materials for removing metals in block copolymers |
US8585938B1 (en) | 2012-03-30 | 2013-11-19 | Novartis Ag | UV-absorbers for ophthalmic lens materials |
US8835581B2 (en) * | 2012-06-08 | 2014-09-16 | Az Electronic Materials (Luxembourg) S.A.R.L. | Neutral layer polymer composition for directed self assembly and processes thereof |
US10457088B2 (en) | 2013-05-13 | 2019-10-29 | Ridgefield Acquisition | Template for self assembly and method of making a self assembled pattern |
US9093263B2 (en) | 2013-09-27 | 2015-07-28 | Az Electronic Materials (Luxembourg) S.A.R.L. | Underlayer composition for promoting self assembly and method of making and using |
US9181449B2 (en) | 2013-12-16 | 2015-11-10 | Az Electronic Materials (Luxembourg) S.A.R.L. | Underlayer composition for promoting self assembly and method of making and using |
US11067893B2 (en) | 2016-12-21 | 2021-07-20 | Merck Patent Gmbh | Compositions and processes for self-assembly of block copolymers |
US10619065B2 (en) | 2017-01-31 | 2020-04-14 | Hewlett-Packard Development Company, L.P. | Photo active agents |
US20230176251A1 (en) * | 2021-09-29 | 2023-06-08 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lenses and their manufacture by in-mold modification |
US11912800B2 (en) | 2021-09-29 | 2024-02-27 | Johnson & Johnson Vision Care, Inc. | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA974981A (en) * | 1970-12-16 | 1975-09-23 | Pennwalt Corporation | Azo or peroxide free radical initiators containing ultraviolet light stabilizing groups |
US3956269A (en) * | 1970-12-16 | 1976-05-11 | Pennwalt Corporation | Azo free radical initiators containing ultraviolet light stabilizing groups |
CA1031200A (en) * | 1973-06-20 | 1978-05-16 | Wesley-Jessen | Ultraviolet absorbing lenses |
US4304895A (en) * | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
US4528311A (en) | 1983-07-11 | 1985-07-09 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles |
NZ208751A (en) * | 1983-07-11 | 1987-04-30 | Iolab Corp | 2-hydroxy-5-acrylyloxyalkylphenyl-2h-benzotriazole derivatives and polymers and copolymers thereof and use as uv absorbing additives in polymer compositions |
EP0133164B1 (en) | 1983-07-26 | 1988-12-14 | Ciba-Geigy Ag | Compounds which can be copolymerised |
DE3439483A1 (en) | 1984-10-27 | 1986-05-07 | Röhm GmbH, 6100 Darmstadt | RADICALLY POLYMERIZABLE UV ABSORBER, METHOD FOR PRODUCING IT AND ITS POLYMERS |
US5141990A (en) | 1985-06-07 | 1992-08-25 | California Institute Of Technology | Photocurable acrylic composition, and U.V. curing with development of U.V. absorber |
US4719248A (en) | 1985-08-08 | 1988-01-12 | Bausch & Lomb Incorporated | Ultraviolet blocking agents for contact lenses |
US4716234A (en) | 1986-12-01 | 1987-12-29 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-(2'-hydroxy-5'-acryloyloxyalkoxyphenyl)-2H-benzotriazole |
JP2683007B2 (en) | 1987-03-03 | 1997-11-26 | アイオーラブ・コーポレーシヨン | Benzotriazole compound, copolymer thereof and ultraviolet absorbing composition |
US5194544A (en) | 1987-10-15 | 1993-03-16 | University Of Florida | UV absorbing vinyl monomers and polymers and ocular implants prepared therefrom |
IL90362A0 (en) | 1988-05-26 | 1989-12-15 | Alcon Lab Inc | Ultraviolet absorbing hydrogels and lenses containing the same |
US5133745A (en) | 1988-05-26 | 1992-07-28 | Alcon Laboratories, Inc. | Ultraviolet absorbing hydrogels |
DE3826947A1 (en) * | 1988-08-09 | 1990-02-22 | Merck Patent Gmbh | THIOXANTHON DERIVATIVES, THEIR USE AS PHOTOINITIATORS, PHOTOPOLYMERIZABLE BINDING SYSTEMS AND METHOD FOR THE PRODUCTION OF A RADIATION-COATED COATING |
US4963160A (en) | 1989-03-14 | 1990-10-16 | Ciba-Geigy Corporation | Reactive uv absorbing compositions and method of preparing lenses therefrom |
US4929250A (en) | 1989-03-14 | 1990-05-29 | Ciba-Geigy Corporation | Ultraviolet absorbing lenses and method of making the same |
US5298033A (en) | 1989-03-14 | 1994-03-29 | Ciba-Geigy Corporation | Ultraviolet absorbing lenses and methods of manufacturing thereof |
US5189084A (en) | 1989-12-21 | 1993-02-23 | Ciba-Geigy Corporation | Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers |
US5290892A (en) * | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
JP2685980B2 (en) | 1990-11-26 | 1997-12-08 | 株式会社メニコン | UV absorbing intraocular lens |
US5164462A (en) | 1991-04-25 | 1992-11-17 | Allergan, Inc. | Ultraviolet light absorbing compounds and silicone compositions |
US5384235A (en) | 1992-07-01 | 1995-01-24 | Eastman Kodak Company | Photographic elements incorporating polymeric ultraviolet absorbers |
ES2182829T3 (en) | 1992-09-07 | 2003-03-16 | Ciba Sc Holding Ag | HYDROXYPHENYL-S-TRIACINES. |
US5331073A (en) * | 1992-11-09 | 1994-07-19 | Allergan, Inc. | Polymeric compositions and intraocular lenses made from same |
US5741905A (en) | 1994-07-23 | 1998-04-21 | Ciba Specialty Chemicals Corporation | Triazine ultraviolet absorbers useful for improving the sun protection factor of textiles |
US5556973A (en) | 1994-07-27 | 1996-09-17 | Ciba-Geigy Corporation | Red-shifted tris-aryl-s-triazines and compositions stabilized therewith |
US5672704A (en) | 1994-10-04 | 1997-09-30 | Ciba-Geigy Corporation | 2-Hydroxyphenyl-s-Triazines substituted with ethylenically unsaturated moieties |
JP3727035B2 (en) * | 1995-03-14 | 2005-12-14 | Hoya株式会社 | Benzotriazole compound, ultraviolet absorber comprising the same, and ophthalmic lens containing the same |
KR100331456B1 (en) | 1995-06-07 | 2002-10-25 | 알콘 래보레이토리스, 인코퍼레이티드 | Improved high refractive index ophthalmic lens materials |
TW325490B (en) | 1995-06-23 | 1998-01-21 | Ciba Sc Holding Ag | Polysiloxane light stabilizers |
FR2744721B1 (en) | 1996-02-12 | 1999-06-18 | Oreal | NOVEL INSOLUBLE S-TRIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND USES THEREOF |
FR2750335B1 (en) | 1996-07-01 | 1998-07-31 | Oreal | COMPOSITIONS COMPRISING 4-TERT-BUTYL-4'- METHOXYDIBENZOYLMETHANE, A DERIVATIVE OF 1, 3, 5-TRIAZINE AND AN (ALPHA-CYANO) -BETA, BETA'-DIPHENYLACRYLATE AND USES |
JP2963945B2 (en) | 1997-05-08 | 1999-10-18 | 大塚化学株式会社 | 2,2'-bis (6-benzotriazolylphenol) compound |
ES2243053T3 (en) * | 1998-04-15 | 2005-11-16 | Alcon Manufacturing Ltd. | MATERIALS OF OPTALMIC DEVICES OF HIGH REFRACTION INDEX, PREPARED USING A METHOD OF RETICULATION AFTER POLYMERIZATION. |
US6218463B1 (en) | 1998-04-20 | 2001-04-17 | Johnson & Johnson Vision Care, Inc. | Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers |
US6036891A (en) | 1998-05-11 | 2000-03-14 | Pharmacia & Upjohn | Polymerizable hydrophilic ultraviolet light absorbing monomers |
US5945465A (en) | 1998-05-15 | 1999-08-31 | Bausch & Lomb Incorporated | Method for polymerizing contact lenses having UV absorbing properties |
US5914355A (en) | 1998-05-15 | 1999-06-22 | Bausch & Lomb Incorporated | Method for making contact lenses having UV absorbing properties |
SE9900935D0 (en) | 1999-03-16 | 1999-03-16 | Pharmacia & Upjohn Bv | Macromolecular compounds |
DE10115434A1 (en) | 2001-03-29 | 2002-10-10 | Huber Fa Michael Muenchen | Prepolymer and anilox roller filling material for variable-depth laser ablation |
US6851804B2 (en) * | 2001-12-28 | 2005-02-08 | Jagdish M. Jethmalani | Readjustable optical elements |
-
2003
- 2003-12-15 ES ES03815211T patent/ES2262033T3/en not_active Expired - Lifetime
- 2003-12-15 EP EP03815211A patent/EP1581272B1/en not_active Expired - Lifetime
- 2003-12-15 JP JP2004566548A patent/JP2006513291A/en not_active Ceased
- 2003-12-15 DK DK03815211T patent/DK1581272T3/en active
- 2003-12-15 AT AT03815211T patent/ATE329629T1/en active
- 2003-12-15 AU AU2003297108A patent/AU2003297108B2/en not_active Ceased
- 2003-12-15 PT PT03815211T patent/PT1581272E/en unknown
- 2003-12-15 WO PCT/US2003/039846 patent/WO2004062371A1/en active IP Right Grant
- 2003-12-15 CA CA002512586A patent/CA2512586A1/en not_active Abandoned
- 2003-12-15 DE DE60306203T patent/DE60306203T2/en not_active Expired - Lifetime
-
2004
- 2004-01-08 US US10/753,254 patent/US7119210B2/en active Active
-
2006
- 2006-08-09 CY CY20061101115T patent/CY1106142T1/en unknown
- 2006-10-09 US US11/539,748 patent/US7396942B2/en not_active Expired - Lifetime
-
2008
- 2008-05-22 US US12/125,403 patent/US7709652B2/en not_active Expired - Lifetime
-
2010
- 2010-03-11 US US12/722,185 patent/US8119830B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2262033T3 (en) | 2006-11-16 |
EP1581272A1 (en) | 2005-10-05 |
US7709652B2 (en) | 2010-05-04 |
US20070078196A1 (en) | 2007-04-05 |
AU2003297108B2 (en) | 2008-01-10 |
DE60306203T2 (en) | 2006-10-05 |
EP1581272B1 (en) | 2006-06-14 |
AU2003297108A1 (en) | 2004-08-10 |
US7396942B2 (en) | 2008-07-08 |
US20100168438A1 (en) | 2010-07-01 |
US7119210B2 (en) | 2006-10-10 |
CY1106142T1 (en) | 2011-06-08 |
WO2004062371A1 (en) | 2004-07-29 |
ATE329629T1 (en) | 2006-07-15 |
US8119830B2 (en) | 2012-02-21 |
DK1581272T3 (en) | 2006-10-02 |
US20040157948A1 (en) | 2004-08-12 |
JP2006513291A (en) | 2006-04-20 |
DE60306203D1 (en) | 2006-07-27 |
PT1581272E (en) | 2006-08-31 |
US20080221675A1 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8119830B2 (en) | Dual function UV-absorbers for ophthalmic lens materials | |
CA2683002C (en) | Uv-absorbers for ophthalmic lens materials | |
KR101745431B1 (en) | Visible light absorbers for ophthalmic lens materials | |
JP5732456B2 (en) | Visible light absorbers for ophthalmic lens materials | |
CA2693845C (en) | Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light | |
US4985559A (en) | UV Absorbing vinyl monomers | |
US8585938B1 (en) | UV-absorbers for ophthalmic lens materials | |
US8236053B1 (en) | 2-amino benzophenone UV-absorbers for ophthalmic lens materials | |
US20100207068A1 (en) | Process for producing purified synthesis gas from synthesis gas comprising trace amounts of sulphur contaminants with a metal-organic framework | |
AU2012383589B2 (en) | 2-amino benzophenone UV-absorbers for ophthalmic lens materials | |
JP2017503905A (en) | UV absorbers for ophthalmic lens materials | |
WO2013025671A1 (en) | Uv-absorbers for ophthalmic lens materials | |
TW201518282A (en) | UV-absorbers for ophthalmic lens materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |